Pharma Mar | PHM - Current Liabilities


Pharma Mar reported EUR93.88M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Akebia Therapeutics USD 162.94M 29.56M Dec/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
Almirall EUR 350.64M 52.12M Dec/2025
Avita Medical AUD 62.68M 77K Dec/2025
Dianthus Therapeutics USD 30.73M 6.88M Dec/2025
Ionis Pharmaceuticals USD 783M 120.46M Dec/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Moderna USD 1.99B 306M Dec/2025
Organon & Co USD 2.68B 117M Sep/2025
Pharma Mar EUR 93.88M 4.94M Dec/2025
Revvity USD 1.33B 108.5M Dec/2025
Tectonic Therapeutic USD 9.67M 293K Dec/2025
Viatris USD 7.09B 269.8M Dec/2025
Xeris Pharmaceuticals USD 109.57M 6.63M Dec/2025